vs
Century Communities, Inc.（CCS）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Century Communities, Inc.的季度营收约是Royalty Pharma plc的1.3倍（$789.7M vs $622.0M），Royalty Pharma plc净利率更高（34.4% vs 3.1%，领先31.3%），Royalty Pharma plc同比增速更快（4.8% vs -12.6%），过去两年Royalty Pharma plc的营收复合增速更高（4.6% vs -12.8%）
二十世纪动画公司是美国知名动画制作工作室，原总部位于洛杉矶世纪城，与福克斯集团的租约到期后迁至伯班克华特迪士尼影城园区。该公司成立于1994年2月，现为华特迪士尼影业旗下二十世纪影业的动画制作分支，出品的动画电影由华特迪士尼影业负责全球院线发行与营销。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
CCS vs RPRX — 直观对比
营收规模更大
CCS
是对方的1.3倍
$622.0M
营收增速更快
RPRX
高出17.3%
-12.6%
净利率更高
RPRX
高出31.3%
3.1%
两年增速更快
RPRX
近两年复合增速
-12.8%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $789.7M | $622.0M |
| 净利润 | $24.4M | $214.2M |
| 毛利率 | — | — |
| 营业利润率 | — | 62.4% |
| 净利率 | 3.1% | 34.4% |
| 营收同比 | -12.6% | 4.8% |
| 净利润同比 | -38.0% | 2.9% |
| 每股收益（稀释后） | $0.88 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CCSRPRX
| Q1 26 | $789.7M | — | ||
| Q4 25 | $1.2B | $622.0M | ||
| Q3 25 | $980.3M | $609.3M | ||
| Q2 25 | $1.0B | $578.7M | ||
| Q1 25 | $903.2M | $568.2M | ||
| Q4 24 | $1.3B | $593.6M | ||
| Q3 24 | $1.1B | $564.7M | ||
| Q2 24 | $1.0B | $537.3M |
净利润CCSRPRX
| Q1 26 | $24.4M | — | ||
| Q4 25 | $36.0M | $214.2M | ||
| Q3 25 | $37.4M | $288.2M | ||
| Q2 25 | $34.9M | $30.2M | ||
| Q1 25 | $39.4M | $238.3M | ||
| Q4 24 | $102.7M | $208.2M | ||
| Q3 24 | $83.0M | $544.0M | ||
| Q2 24 | $83.7M | $102.0M |
营业利润率CCSRPRX
| Q1 26 | — | — | ||
| Q4 25 | 3.8% | 62.4% | ||
| Q3 25 | 4.9% | 70.1% | ||
| Q2 25 | 4.7% | 36.3% | ||
| Q1 25 | 5.8% | 94.0% | ||
| Q4 24 | 10.6% | 60.9% | ||
| Q3 24 | 9.7% | — | ||
| Q2 24 | 10.6% | 50.2% |
净利率CCSRPRX
| Q1 26 | 3.1% | — | ||
| Q4 25 | 2.9% | 34.4% | ||
| Q3 25 | 3.8% | 47.3% | ||
| Q2 25 | 3.5% | 5.2% | ||
| Q1 25 | 4.4% | 41.9% | ||
| Q4 24 | 8.1% | 35.1% | ||
| Q3 24 | 7.3% | 96.3% | ||
| Q2 24 | 8.1% | 19.0% |
每股收益（稀释后）CCSRPRX
| Q1 26 | $0.88 | — | ||
| Q4 25 | $1.21 | $0.49 | ||
| Q3 25 | $1.25 | $0.67 | ||
| Q2 25 | $1.14 | $0.07 | ||
| Q1 25 | $1.26 | $0.55 | ||
| Q4 24 | $3.20 | $0.46 | ||
| Q3 24 | $2.59 | $1.21 | ||
| Q2 24 | $2.61 | $0.23 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $78.2M | $618.7M |
| 总债务越低越好 | — | $9.0B |
| 股东权益账面价值 | $2.6B | $9.7B |
| 总资产 | $4.5B | $19.6B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资CCSRPRX
| Q1 26 | $78.2M | — | ||
| Q4 25 | $109.4M | $618.7M | ||
| Q3 25 | $130.1M | $938.9M | ||
| Q2 25 | $93.2M | $631.9M | ||
| Q1 25 | $100.3M | $1.1B | ||
| Q4 24 | $150.0M | $929.0M | ||
| Q3 24 | $149.2M | $950.1M | ||
| Q2 24 | $106.7M | $1.8B |
总债务CCSRPRX
| Q1 26 | — | — | ||
| Q4 25 | — | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B |
股东权益CCSRPRX
| Q1 26 | $2.6B | — | ||
| Q4 25 | $2.6B | $9.7B | ||
| Q3 25 | $2.6B | $9.6B | ||
| Q2 25 | $2.6B | $9.5B | ||
| Q1 25 | $2.6B | $9.8B | ||
| Q4 24 | $2.6B | $10.3B | ||
| Q3 24 | $2.5B | $10.3B | ||
| Q2 24 | $2.5B | $9.8B |
总资产CCSRPRX
| Q1 26 | $4.5B | — | ||
| Q4 25 | $4.5B | $19.6B | ||
| Q3 25 | $4.7B | $19.3B | ||
| Q2 25 | $4.6B | $18.3B | ||
| Q1 25 | $4.6B | $17.6B | ||
| Q4 24 | $4.5B | $18.2B | ||
| Q3 24 | $4.8B | $18.0B | ||
| Q2 24 | $4.3B | $17.7B |
负债/权益比CCSRPRX
| Q1 26 | — | — | ||
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $827.1M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 3.86× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流CCSRPRX
| Q1 26 | — | — | ||
| Q4 25 | $210.7M | $827.1M | ||
| Q3 25 | $-10.0M | $702.6M | ||
| Q2 25 | $-11.0M | $364.0M | ||
| Q1 25 | $-36.6M | $596.1M | ||
| Q4 24 | $299.7M | $742.5M | ||
| Q3 24 | $-95.5M | $703.6M | ||
| Q2 24 | $-100.1M | $658.2M |
自由现金流CCSRPRX
| Q1 26 | — | — | ||
| Q4 25 | $202.6M | — | ||
| Q3 25 | $-20.8M | — | ||
| Q2 25 | $-17.6M | — | ||
| Q1 25 | $-40.0M | — | ||
| Q4 24 | $290.6M | — | ||
| Q3 24 | $-101.9M | — | ||
| Q2 24 | $-117.6M | — |
自由现金流率CCSRPRX
| Q1 26 | — | — | ||
| Q4 25 | 16.4% | — | ||
| Q3 25 | -2.1% | — | ||
| Q2 25 | -1.8% | — | ||
| Q1 25 | -4.4% | — | ||
| Q4 24 | 22.8% | — | ||
| Q3 24 | -9.0% | — | ||
| Q2 24 | -11.3% | — |
资本支出强度CCSRPRX
| Q1 26 | — | — | ||
| Q4 25 | 0.7% | — | ||
| Q3 25 | 1.1% | — | ||
| Q2 25 | 0.7% | — | ||
| Q1 25 | 0.4% | — | ||
| Q4 24 | 0.7% | — | ||
| Q3 24 | 0.6% | — | ||
| Q2 24 | 1.7% | — |
现金转化率CCSRPRX
| Q1 26 | — | — | ||
| Q4 25 | 5.86× | 3.86× | ||
| Q3 25 | -0.27× | 2.44× | ||
| Q2 25 | -0.32× | 12.06× | ||
| Q1 25 | -0.93× | 2.50× | ||
| Q4 24 | 2.92× | 3.57× | ||
| Q3 24 | -1.15× | 1.29× | ||
| Q2 24 | -1.20× | 6.45× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CCS
| Home sales revenues | $734.1M | 93% |
| Land sales and other revenues | $33.2M | 4% |
| Financial services revenues | $22.4M | 3% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
